Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cacabelos

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
The Tohoku Journal of Experimental Medicine|April 1, 1987
Time- and dose-dependent responses of brain histamine to intracerebroventricular and intraperitoneal administrations of growth hormone-releasing factor (GRF1-44)R Cacabelos, A Yamatodani, H Fukui, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1996
APOE-related frequency of cognitive and noncognitive symptoms in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1996
Effects of S-9977-2 on histamine levels in ratsL Fernández-Novoa, X A Alvarez, S Détolle-Sarbach, et al.
European Journal of Neurology|May 27, 2010
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of CerebrolysinX A Alvarez, R Cacabelos, C Sampedro, et al.
Biological Psychiatry|February 1, 1991
Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementiaM Martin-Loeches, P Gil, F Jimenez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1989
Brain histamine in Alzheimer's diseaseR Cacabelos, A Yamatodani, H Niigawa, et al.
Acta Endocrinologica|March 1, 1988
GHRH-induced GH response in patients with senile dementia of the Alzheimer typeR Cacabelos, H Niigawa, Y Ikemura, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1996
Apoptosis during HIV infection and in neurodegenerative disordersV R Lombardi, J J Miguel-Hidalgo, G Mancino, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Cerebrovascular changes associated with interleukin-1 beta (IL-1 beta) and histamine (HA) levels in Alzheimer's diseaseX A Alvarez, L Fernández-Novoa, J Caamaño, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
The Tohoku Journal of Experimental Medicine|April 1, 1987
Time- and dose-dependent responses of brain histamine to intracerebroventricular and intraperitoneal administrations of growth hormone-releasing factor (GRF1-44)R Cacabelos, A Yamatodani, H Fukui, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1996
APOE-related frequency of cognitive and noncognitive symptoms in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1996
Effects of S-9977-2 on histamine levels in ratsL Fernández-Novoa, X A Alvarez, S Détolle-Sarbach, et al.
European Journal of Neurology|May 27, 2010
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of CerebrolysinX A Alvarez, R Cacabelos, C Sampedro, et al.
Biological Psychiatry|February 1, 1991
Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementiaM Martin-Loeches, P Gil, F Jimenez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1989
Brain histamine in Alzheimer's diseaseR Cacabelos, A Yamatodani, H Niigawa, et al.
Acta Endocrinologica|March 1, 1988
GHRH-induced GH response in patients with senile dementia of the Alzheimer typeR Cacabelos, H Niigawa, Y Ikemura, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1996
Apoptosis during HIV infection and in neurodegenerative disordersV R Lombardi, J J Miguel-Hidalgo, G Mancino, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Cerebrovascular changes associated with interleukin-1 beta (IL-1 beta) and histamine (HA) levels in Alzheimer's diseaseX A Alvarez, L Fernández-Novoa, J Caamaño, et al.
Pageof 11